title: Changing stable heart transplant recipients from Sandimmune to Neoral.
authors.affiliation: Analytical Unit, St George's Hospital, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Dalrymple-Hay
authors.forename: M
authors.initials: M
authors.lastname: Meara
authors.forename: L
authors.initials: L
authors.lastname: Reynolds
authors.forename: L
authors.initials: L
authors.lastname: Backhouse
authors.forename: D
authors.initials: D
authors.lastname: Wright
authors.forename: D
authors.initials: D
authors.lastname: Holt
authors.forename: A
authors.initials: A
authors.lastname: Johnston
authors.forename: B
authors.initials: B
authors.lastname: Madden
authors.forename: A
authors.initials: A
authors.lastname: Murday
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004304:Dosage Forms; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine